DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 71 filers reported holding DERMA SCIENCES INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $144,000 | -25.4% | 30,595 | +13.2% | 0.00% | -50.0% |
| Q2 2015 | $193,000 | +31.3% | 27,020 | +55.8% | 0.00% | +100.0% |
| Q1 2015 | $147,000 | +6.5% | 17,340 | +16.8% | 0.00% | 0.0% |
| Q4 2014 | $138,000 | -22.0% | 14,850 | -30.1% | 0.00% | -50.0% |
| Q3 2014 | $177,000 | +13.5% | 21,240 | +57.7% | 0.00% | 0.0% |
| Q2 2014 | $156,000 | -11.9% | 13,470 | -3.6% | 0.00% | 0.0% |
| Q1 2014 | $177,000 | -56.7% | 13,980 | -63.0% | 0.00% | -60.0% |
| Q4 2013 | $409,000 | – | 37,780 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |